MICHAEL W HENIFF
Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease PALOS HEIGHTS, IL NPI 1790724417
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease IL GlaxoSmithKline, LLC. All categories
General Payments — all program years on this page
$12,069.49
- Category: General Payments
- Program years: PY2018–2024
- Record count: 699
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $189.29 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $189.29 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $77.03 | 4 |
| Amgen Inc. | $46.34 | 2 |
| Mylan Specialty L.P. | $43.99 | 2 |
| Acerta Pharma LLC | $21.93 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1105298033 | AstraZeneca Pharmaceuticals LP | $21.93 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115715241 | Amgen Inc. | $18.92 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115715246 | Amgen Inc. | $27.42 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115937585 | GlaxoSmithKline, LLC. | $20.10 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116480931 | GlaxoSmithKline, LLC. | $13.26 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116521826 | GlaxoSmithKline, LLC. | $22.57 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116530952 | GlaxoSmithKline, LLC. | $21.10 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147291969 | Mylan Specialty L.P. | $20.77 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147306724 | Mylan Specialty L.P. | $23.22 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.